Steve Potkin
University of California, Irvine
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Steve Potkin.
Molecular Psychiatry | 2016
T G M van Erp; Derrek P. Hibar; Jerod Rasmussen; David C. Glahn; Godfrey D. Pearlson; Ole A. Andreassen; Ingrid Agartz; Lars T. Westlye; Unn K. Haukvik; Anders M. Dale; Ingrid Melle; Cecilie B. Hartberg; Oliver Gruber; Bernd Kraemer; David Zilles; Gary Donohoe; Sinead Kelly; Colm McDonald; Derek W. Morris; Dara M. Cannon; Aiden Corvin; Marise W J Machielsen; Laura Koenders; L. de Haan; Dick J. Veltman; Theodore D. Satterthwaite; Daniel H. Wolf; R.C. Gur; Raquel E. Gur; Steve Potkin
The profile of brain structural abnormalities in schizophrenia is still not fully understood, despite decades of research using brain scans. To validate a prospective meta-analysis approach to analyzing multicenter neuroimaging data, we analyzed brain MRI scans from 2028 schizophrenia patients and 2540 healthy controls, assessed with standardized methods at 15 centers worldwide. We identified subcortical brain volumes that differentiated patients from controls, and ranked them according to their effect sizes. Compared with healthy controls, patients with schizophrenia had smaller hippocampus (Cohen’s d=−0.46), amygdala (d=−0.31), thalamus (d=−0.31), accumbens (d=−0.25) and intracranial volumes (d=−0.12), as well as larger pallidum (d=0.21) and lateral ventricle volumes (d=0.37). Putamen and pallidum volume augmentations were positively associated with duration of illness and hippocampal deficits scaled with the proportion of unmedicated patients. Worldwide cooperative analyses of brain imaging data support a profile of subcortical abnormalities in schizophrenia, which is consistent with that based on traditional meta-analytic approaches. This first ENIGMA Schizophrenia Working Group study validates that collaborative data analyses can readily be used across brain phenotypes and disorders and encourages analysis and data sharing efforts to further our understanding of severe mental illness.
Human Brain Mapping | 2009
Kim Il Dae; Dara S. Manoach; Daniel H. Mathalon; Jessica A. Turner; Maggie V. Mannell; Greg Brown; Judith M. Ford; Randy L. Gollub; Tonya White; Cynthia G. Wible; Aysenil Belger; H. Jeremy Bockholt; Vince P. Clark; John Lauriello; Daniel S. O'Leary; Bryon A. Mueller; Kelvin O. Lim; Nancy C. Andreasen; Steve Potkin; Vince D. Calhoun
Deficits in working memory (WM) are a consistent neurocognitive marker for schizophrenia. Previous studies have suggested that WM is the product of coordinated activity in distributed functionally connected brain regions. Independent component analysis (ICA) is a data‐driven approach that can identify temporally coherent networks that underlie fMRI activity. We applied ICA to an fMRI dataset for 115 patients with chronic schizophrenia and 130 healthy controls by performing the Sternberg Item Recognition Paradigm. Here, we describe the first results using ICA to identify differences in the function of WM networks in schizophrenia compared to controls. ICA revealed six networks that showed significant differences between patients with schizophrenia and healthy controls. Four of these networks were negatively task‐correlated and showed deactivation across the posterior cingulate, precuneus, medial prefrontal cortex, anterior cingulate, inferior parietal lobules, and parahippocampus. These networks comprise brain regions known as the default‐mode network (DMN), a well‐characterized set of regions shown to be active during internal modes of cognition and implicated in schizophrenia. Two networks were positively task‐correlated, with one network engaging WM regions such as bilateral DLPFC and inferior parietal lobules while the other network engaged primarily the cerebellum. Our results suggest that DLPFC dysfunction in schizophrenia might be lateralized to the left and intrinsically tied to other regions such as the inferior parietal lobule and cingulate gyrus. Furthermore, we found that DMN dysfunction in schizophrenia exists across multiple subnetworks of the DMN and that these subnetworks are individually relevant to the pathophysiology of schizophrenia. In summary, this large multsite study identified multiple temporally coherent networks, which are aberrant in schizophrenia versus healthy controls and suggests that both task‐correlated and task‐anticorrelated networks may serve as potential biomarkers. Hum Brain Mapp, 2009.
Molecular Psychiatry | 2015
Z Tan; Wei Dai; T G M van Erp; J Overman; Angelo Demuro; M A Digman; A Hatami; R Albay; E M Sontag; K T Potkin; Shichun Ling; Fabio Macciardi; William E. Bunney; Jeffrey D. Long; Jane S. Paulsen; J M Ringman; Ian Parker; Charles G. Glabe; Leslie M. Thompson; Wah Chiu; Steve Potkin
Huntington’s disease (HD), a progressive neurodegenerative disease, is caused by an expanded CAG triplet repeat producing a mutant huntingtin protein (mHTT) with a polyglutamine-repeat expansion. Onset of symptoms in mutant huntingtin gene-carrying individuals remains unpredictable. We report that synthetic polyglutamine oligomers and cerebrospinal fluid (CSF) from BACHD transgenic rats and from human HD subjects can seed mutant huntingtin aggregation in a cell model and its cell lysate. Our studies demonstrate that seeding requires the mutant huntingtin template and may reflect an underlying prion-like protein propagation mechanism. Light and cryo-electron microscopy show that synthetic seeds nucleate and enhance mutant huntingtin aggregation. This seeding assay distinguishes HD subjects from healthy and non-HD dementia controls without overlap (blinded samples). Ultimately, this seeding property in HD patient CSF may form the basis of a molecular biomarker assay to monitor HD and evaluate therapies that target mHTT.
Human Psychopharmacology-clinical and Experimental | 2009
Renan P. Souza; Maria Tampakeras; Vince Basile; Takahiro Shinkai; Daniela V.F. Rosa; Steve Potkin; Herbert Y. Meltzer; Jeffrey A. Lieberman; Marco Aurélio Romano-Silva; James L. Kennedy
Abnormal activities of critical antioxidant enzymes and other indices of lipid peroxidation in plasma and red blood cells were detected in patients with schizophrenia. Other results have shown that oxidative stress may be modulated by clozapine. Based on that and some studies already found different clinical relations between reactive oxygen species and negative and positive symptoms, we evaluated association between clinical response and the polymorphism in the human glutathione peroxidase (GPX1) (Pro200Leu, rs1050450) and manganese SOD (MNSOD) (Ala16Val, rs4880) gene in 216 clozapine‐treated patients with schizophrenia. No association was found with these two functional polymorphisms and clozapine response and symptom change after 6 months. No correlations were found between positive/negative symptoms score and both polymorphisms. Our results present that GPX1 (Pro200Leu) and MNSOD (Ala16Val) polymorphisms seem do not play a central role in the clozapine response, although studies in larger and independent samples are necessary to confirm our findings. Copyright
Psychological Medicine | 2018
Esther Walton; Derrek P. Hibar; T G M van Erp; Steve Potkin; Roberto Roiz-Santiañez; Benedicto Crespo-Facorro; P. Suarez-Pinilla; N. E. M. van Haren; S. M.C. De Zwarte; R.S. Kahn; Wiepke Cahn; Nhat Trung Doan; Kjetil N. Jørgensen; Tiril P. Gurholt; Ingrid Agartz; Ole A. Andreassen; Lars T. Westlye; Ingrid Melle; Akiah Ottesen Berg; Lynn Mørch-Johnsen; Ann Faerden; Lena Flyckt; Helena Fatouros-Bergman; Erik G. Jönsson; Ryota Hashimoto; Hidenaga Yamamori; Masaki Fukunaga; Neda Jahanshad; P. De Rossi; F. Piras
BACKGROUND Our understanding of the complex relationship between schizophrenia symptomatology and etiological factors can be improved by studying brain-based correlates of schizophrenia. Research showed that impairments in value processing and executive functioning, which have been associated with prefrontal brain areas [particularly the medial orbitofrontal cortex (MOFC)], are linked to negative symptoms. Here we tested the hypothesis that MOFC thickness is associated with negative symptom severity. METHODS This study included 1985 individuals with schizophrenia from 17 research groups around the world contributing to the ENIGMA Schizophrenia Working Group. Cortical thickness values were obtained from T1-weighted structural brain scans using FreeSurfer. A meta-analysis across sites was conducted over effect sizes from a model predicting cortical thickness by negative symptom score (harmonized Scale for the Assessment of Negative Symptoms or Positive and Negative Syndrome Scale scores). RESULTS Meta-analytical results showed that left, but not right, MOFC thickness was significantly associated with negative symptom severity (β std = -0.075; p = 0.019) after accounting for age, gender, and site. This effect remained significant (p = 0.036) in a model including overall illness severity. Covarying for duration of illness, age of onset, antipsychotic medication or handedness weakened the association of negative symptoms with left MOFC thickness. As part of a secondary analysis including 10 other prefrontal regions further associations in the left lateral orbitofrontal gyrus and pars opercularis emerged. CONCLUSIONS Using an unusually large cohort and a meta-analytical approach, our findings point towards a link between prefrontal thinning and negative symptom severity in schizophrenia. This finding provides further insight into the relationship between structural brain abnormalities and negative symptoms in schizophrenia.
Acta Psychiatrica Scandinavica | 2017
Esther Walton; Derrek P. Hibar; T G M van Erp; Steve Potkin; Roberto Roiz-Santiañez; Benedicto Crespo-Facorro; P. Suarez-Pinilla; N. E. M. van Haren; S. M.C. De Zwarte; R.S. Kahn; Wiepke Cahn; Nhat Trung Doan; Kjetil N. Jørgensen; Tiril P. Gurholt; Ingrid Agartz; Ole A. Andreassen; Lars T. Westlye; Ingrid Melle; Akiah Ottesen Berg; Lynn Mørch-Johnsen; Ann Faerden; Lena Flyckt; Helena Fatouros-Bergman; Erik G. Jönsson; Ryota Hashimoto; Hidenaga Yamamori; Masaki Fukunaga; A. Preda; P. De Rossi; F. Piras
Based on the role of the superior temporal gyrus (STG) in auditory processing, language comprehension and self‐monitoring, this study aimed to investigate the relationship between STG cortical thickness and positive symptom severity in schizophrenia.
Brain Imaging and Behavior | 2016
Newman E; Terry L. Jernigan; Krista M. Lisdahl; Leanne Tamm; Susan F. Tapert; Steve Potkin; Daniel H. Mathalon; Brooke S. G. Molina; James M. Bjork; Francisco Xavier Castellanos; James M. Swanson; Joshua M. Kuperman; Hauke Bartsch; Chi-Hua Chen; Anders M. Dale; Jeffery N. Epstein
Response inhibition deficits are widely believed to be at the core of Attention-Deficit Hyperactivity Disorder (ADHD). Several studies have examined neural architectural correlates of ADHD, but research directly examining structural correlates of response inhibition is lacking. Here we examine the relationship between response inhibition as measured by a Go/No Go task, and cortical surface area and thickness of the caudal inferior frontal gyrus (cIFG), a region implicated in functional imaging studies of response inhibition, in a sample of 114 young adults with and without ADHD diagnosed initially during childhood. We used multiple linear regression models to test the hypothesis that Go/No Go performance would be associated with cIFG surface area or thickness. Results showed that poorer Go/No Go performance was associated with thicker cIFG cortex, and this effect was not mediated by ADHD status or history of substance use. However, independent of Go/No Go performance, persistence of ADHD symptoms and more frequent cannabis use were associated with thinner cIFG. Go/No Go performance was not associated with cortical surface area. The association between poor inhibitory functioning and thicker cIFG suggests that maturation of this region may differ in low performing participants. An independent association of persistent ADHD symptoms and frequent cannabis use with thinner cIFG cortex suggests that distinct neural mechanisms within this region may play a role in inhibitory function, broader ADHD symptomatology, and cannabis use. These results contribute to Research Domain Criteria (RDoC) by revealing novel associations between neural architectural phenotypes and basic neurobehavioral processes measured dimensionally.
Journal of Developmental and Physical Disabilities | 1993
Tim Wigal; Diane L. Christian; Sharon B. Wigal; James M. Swanson; Francis M. Crinella; Steve Potkin; Dan Carreon; Valerie Ackerland; Donald B. Dean
We evaluated the incidence of three types of tardive dyskinesia (withdrawal, persistent, and masked) in the context of clinically determined changes in neuroleptic medication status in persons with developmental disabilities. We investigated 56 subjects residing at a public residential facility. Based on changes in neuroleptic dosage over a ten-month period, four groups were formed: (1) significantly decreased dose, (2) slightly decreased dose, (3) no change, and (4) increased dose. Withdrawal TD was observed in about 60% of the subjects in the group defined by a significant decrease in dose. Persistent TD was observed in approximately 50% of the subjects in the two groups defined by little or no change in medication (slight decrease and no change in dose). Masked TD was observed in 60% of the subjects in the group defined by an increase in dose. Categorizing TD in this fashion may aid in its early diagnosis and subsequent treatment.
Psychological Medicine | 2018
Jamie Ferri; J.M. Ford; Brian J. Roach; Jessica A. Turner; T G M van Erp; James T. Voyvodic; Adrian Preda; Aysenil Belger; Juan Bustillo; Daniel S. O'Leary; Bryon A. Mueller; Kelvin O. Lim; Sarah McEwen; V.D. Calhoun; Michele T. Diaz; Gary H. Glover; Douglas N. Greve; Cynthia G. Wible; Jatin G. Vaidya; Steve Potkin; Daniel H. Mathalon
BACKGROUND Schizophrenia (SZ) is a severe neuropsychiatric disorder associated with disrupted connectivity within the thalamic-cortico-cerebellar network. Resting-state functional connectivity studies have reported thalamic hypoconnectivity with the cerebellum and prefrontal cortex as well as thalamic hyperconnectivity with sensory cortical regions in SZ patients compared with healthy comparison participants (HCs). However, fundamental questions remain regarding the clinical significance of these connectivity abnormalities. METHOD Resting state seed-based functional connectivity was used to investigate thalamus to whole brain connectivity using multi-site data including 183 SZ patients and 178 matched HCs. Statistical significance was based on a voxel-level FWE-corrected height threshold of p < 0.001. The relationships between positive and negative symptoms of SZ and regions of the brain demonstrating group differences in thalamic connectivity were examined. RESULTS HC and SZ participants both demonstrated widespread positive connectivity between the thalamus and cortical regions. Compared with HCs, SZ patients had reduced thalamic connectivity with bilateral cerebellum and anterior cingulate cortex. In contrast, SZ patients had greater thalamic connectivity with multiple sensory-motor regions, including bilateral pre- and post-central gyrus, middle/inferior occipital gyrus, and middle/superior temporal gyrus. Thalamus to middle temporal gyrus connectivity was positively correlated with hallucinations and delusions, while thalamus to cerebellar connectivity was negatively correlated with delusions and bizarre behavior. CONCLUSIONS Thalamic hyperconnectivity with sensory regions and hypoconnectivity with cerebellar regions in combination with their relationship to clinical features of SZ suggest that thalamic dysconnectivity may be a core neurobiological feature of SZ that underpins positive symptoms.
bioRxiv | 2018
A. Iraji; Zening Fu; E. Damarajua; T. DeRamus; Noah Lewis; Juan Bustillo; R. K. Lenroot; Aysenil Belger; J.M. Ford; Sarah McEwen; Daniel H. Mathalon; Bryon A. Mueller; Godfrey D. Pearlson; Steve Potkin; Adrian Preda; Jessica A. Turner; Jatin G. Vaidya; T G M van Erp; Vince D. Calhoun
The analysis of time-varying activity and connectivity patterns (i.e., the chronnectome) using resting-state magnetic resonance imaging has become an important part of ongoing neuroscience discussions. The majority of previous work has focused on variations of temporal coupling among fixed spatial nodes or transition of the dominant activity/connectivity pattern over time. Here, we introduce an approach to capture spatial dynamics within functional domains (FD), as well as temporal dynamics within and between FD. The approach models the brain as a hierarchical functional architecture with different levels of granularity, where lower levels have higher functional homogeneity and less dynamic behavior and higher levels have less homogeneity and more dynamic behavior. First, a high-order spatial independent component analysis is used to approximate functional units. A functional unit is a pattern of regions with very similar functional activity over time. Next, functional units are used to construct FDs. Finally, functional modules (FMs) are calculated from FDs, providing an overall view of brain dynamics. Results highlight the spatial fluidity within FDs, including a broad spectrum of changes in regional associations from strong coupling to complete decoupling. Moreover, FMs capture the dynamic interplay between FDs. Patients with schizophrenia show transient reductions in functional activity and state connectivity across several FDs, particularly the subcortical domain. Activity and connectivity differences convey unique information in many cases (e.g. the default mode) highlighting their complementarity information. The proposed hierarchical model to capture FD spatiotemporal variation provides new insight into the macroscale chronnectome and identifies changes hidden from existing approaches.